Verona Pharma plc (NASDAQ:VRNA) Receives Average Recommendation of "Buy" from Analysts
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) has been given a consensus recommendation of “Buy” by the five ratings firms that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued ratings on the […]